AngioDynamics (NSDQ:ANGO) announced that it removed the interim label from CFO Stephen Trowbridge’s title, making him the company’s permanent CFO while appointing him to the role of executive VP.
Trowbridge had served as interim CFO since Oct. 22, 2019, and was officially placed in the role on Feb. 5, 2020. He also served as a senior VP and as general counsel. Trowbridge is set to retain his duties as general counsel until a replacement is named, according to a news release.
“I am excited to assume the CFO role on a permanent basis,” Trowbridge said in the news release. “I look forward to continuing to work closely with [president & CEO Jim Clemmer] and the rest of the team as we enter larger, faster-growing markets and bring innovative new products to healthcare professionals and patients around the globe.”
Trowbridge joined AngioDynamics as corporate counsel in 2008 and earned a promotion to VP and general counsel in 2010, followed by a promotion to senior VP, general counsel in 2013.
Before AngioDynamics, Trowbridge held the role of corporate counsel at Philips Healthcare and Intermagnetics General Corporation.